Across TCGA pan-cancer cohorts, RNU6-1293P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-1293P data layer.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher RNU6-1293P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1293P expression acts as an unfavorable survival marker.

GBM and KIRP are the cancer types where RNU6-1293P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.062	0.413	<.001	36	view →
KIRP	OS	Tertile	All	0.192	0.705	.015	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-1293P tumor-vs-normal RNA expression · all RNU6-1293P data types